Sporadic inclusion body Myositis: MRI findings and correlation with clinical and functional parameters

American Journal of Roentgenology

Volumn 209, Issue 6, 2017, Pages 1340-1347

  Guimaraes, Julio Brandao ^a,b,c   Zanoteli, Edmar ^d   Link, Thomas M ^b   De Camargo, Leonardo V ^d   Facchetti, Luca ^b,e   Nardo, Lorenzo ^b   Da Rocha Correa Fernandes, Artur ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DASA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Atrophy; Fat infiltration; Idiopathic myopathy; Inflammatory myopathies; MRI; Sporadic body inclusion myositis

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; EDEMA; FEMALE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; LABORATORY TEST; LOWER LIMB; MALE; MEDICAL RESEARCH COUNCIL SCALE; MIDDLE AGED; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE FATTY INFILTRATION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; BIOPSY; DIAGNOSTIC IMAGING; DISABILITY; LIMB; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

AGED; BIOPSY; DISABILITY EVALUATION; EXTREMITIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; PROSPECTIVE STUDIES;

EID: 85035211852     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.17.17849     Document Type: Article

References (27)

1. Weihl CC, Pestronk A. Sporadic inclusion body myositis: Possible pathogenesis inferred from biomarkers. Curr Opin Neurol 2010; 23:482-488
2. Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA. A 12-year follow-up in sporadic inclusion body myositis: An end stage with major disabilities. Brain 2011; 134:3167-3175
3. Ringel SP, Kenny CE, Neville HE, Giorno R, Carry MR. Spectrum of inclusion body myositis. Arch Neurol 1987; 44:1154-1157
4. Machado P, Brady S, Hanna MG. Update in inclusion body myositis. Curr Opin Rheumatol 2013; 25:763-771
5. Benveniste O, Guiguet M, Freebody J, et al. Longterm observational study of sporadic inclusion body myositis. Brain 2011; 134:3176-3184
6. Mastaglia FL, Needham M. Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J Clin Neurosci 2015; 22:6-13
7. Murphy WA, Totty WG, Carroll JE. MRI of normal and pathologic skeletal muscle. AJR 1986; 146:565-574
8. Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010; 20:2447-2460
9. Amato AA, Sivakumar K, Goyal N, et al. Treatment of sporadic inclusion body myositis with bimagrumab. Neurology 2014; 83:2239-2246
10. Forbes SC, Willcocks RJ, Rooney WD, Walter GA, Vandenborne K. MRI quantifies neuromuscular disease progression. Lancet Neurol 2016; 15:26-28
11. Arpan I, Willcocks RJ, Forbes SC, et al. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology 2014; 83:974-980
12. Medical Research Council. Aids to the examination of the peripheral nervous system. London, UK: Balliere Tindall, 1986
13. Cortese A, Machado P, Morrow J, et al. Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials. Neuromuscul Disord 2013; 23:404-412
14. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988; 19:1497-1500
15. Bronner IM, van der Meulen MF, de Visser M, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65:1456-1461
16. Jackson CE. A clinical approach to muscle diseases. Semin Neurol 2008; 28:228-240
17. Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. Fatty muscle degeneration in cuff ruptures: Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 1994; 304:78-83
18. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002; 29:1897-1906
19. Tasca G, Monforte M, De Fino C, Kley RA, Ricci E, Mirabella M. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve 2015; 52:956-962
20. Morrow JM, Matthews E, Raja Rayan DL, et al. Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord 2013; 23:637-646
21. Cox FM, Reijnierse M, van Rijswijk CS, Wintzen AR, Verschuuren JJ, Badrising UA. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxford) 2011; 50:1153-1161
22. Phillips BA, Cala LA, Thickbroom GW, Melsom A, Zilko PJ, Mastaglia FL. Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study. Muscle Nerve 2001; 24:1526-1534
23. Sekul EA, Chow C, Dalakas MC. Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology 1997; 48:863-866
24. Ten Dam L, van der Kooi AJ, Verhamme C, Wattjes MP, de Visser M. Muscle imaging in inherited and acquired muscle diseases. Eur J Neurol 2016; 23:688-703
25. Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 2014; 83:426-433
26. Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K. Assessment of active inflammation in juvenile dermatomyositis: A novel magnetic resonance imaging-based scoring system. Rheumatology (Oxford) 2011; 50:2237-2244
27. Maillard SM, Jones R, Owens C, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004; 43:603-608